Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-09-043950
Filing Date
2009-09-18
Accepted
2009-09-17 19:47:03
Documents
4
Period of Report
2009-11-09
Effectiveness Date
2009-09-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT y02239def14a.htm DEF 14A 388520
2 GRAPHIC y02239y0223901.gif GRAPHIC 1515
3 GRAPHIC y02239y0223902.gif GRAPHIC 3210
4 GRAPHIC y02239y0223903.gif GRAPHIC 3443
  Complete submission text file 0000950123-09-043950.txt   401919
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 091075467
SIC: 2836 Biological Products, (No Diagnostic Substances)